Using Large Language Models to Predict Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Proof-of-Concept Analysis

GPT-based LLMs show strong potential for predicting advanced fibrosis in MASLD, offering a scalable, interpretable tool for clinical use. Further validation across diverse populations and clinical settings is needed to confirm generalizability and refine the approach before clinical adoption.